Tezspire 210 mg solution for injection in pre-filled syringe
- Licence status
- Active substances
- Tezepelumab
- Dosage Form
- Solution for injection in pre-filled syringe
- Licence number
- EU/1/22/1677/001-002
- Licence holder
- AstraZeneca AB
Product documents
- Package Leaflet
- Summary of Product Characteristics
- Public Assessment Report
Licence information
- ATC code
- R03DX11 tezepelumab
- Legal supply status
- Product subject to prescription which may not be renewed (A)
- Place of sale
- Supply through pharmacies only
- Conditions of Licence
- Medicinal product subject to restricted medical prescription (see Annex I: Summary of Product Characteristics, section 4.2)
- Marketing availability
- Unknown
- Advertising conditions
- Advertising to healthcare professionals only
- Licence issued
- 19/09/2022